| Literature DB >> 21247809 |
Rommy Teran1, Edward Mitre, Maritza Vaca, Silvia Erazo, Gisela Oviedo, Marc P Hübner, Martha E Chico, Joseph J Mattapallil, Quentin Bickle, Laura C Rodrigues, Philip J Cooper.
Abstract
The immune response that develops in early childhood underlies the development of inflammatory diseases such as asthma and there are few data from tropical Latin America (LA). This study investigated the effects of age on the development of immunity during the first 5 years of life by comparing innate and adaptive immune responses in Ecuadorian children aged 6-9 months, 22-26 months, and 48-60 months. Percentages of naïve CD4+ T cells declined with age while those of memory CD4(+) and CD8(+) T cells increased indicating active development of the immune system throughout the first five years. Young infants had greater innate immune responses to TLR agonists compared to older children while regulatory responses including SEB-induced IL-10 and percentages of FoxP3(+) T-regulatory cells decreased with age. Enhanced innate immunity in early life may be important for host defense against pathogens but may increase the risk of immunopathology.Entities:
Mesh:
Substances:
Year: 2011 PMID: 21247809 PMCID: PMC3043252 DOI: 10.1016/j.clim.2010.12.011
Source DB: PubMed Journal: Clin Immunol ISSN: 1521-6616 Impact factor: 3.969
Baseline characteristics of study population.
| Characteristic | Rural ( | Urban ( | |
|---|---|---|---|
| Age (months) | |||
| Median (range) | 25 (6–60) | 25 (6–60) | |
| Sex | |||
| Male/female (%) | 49.6/40.4 | 37.2/62.8 | 0.04 |
| Maternal educational level (%) | |||
| Don't know | 0.9 | 0.8 | |
| Illiterate | 4.5 | 3.2 | |
| Primary complete | 38.7 | 28.4 | |
| Secondary complete | 55.9 | 67.6 | 0.16 |
| Monthly income (US$) | |||
| Median (range) | 100 (20–500) | 100 (20–1500) | 0.10 |
| Breastfeeding duration (months) | |||
| Don't know | 1.8% | 0% | |
| < 6 months | 3.7% | 5.6% | |
| 6–12 months | 63.3% | 68.2% | |
| 13–24 months | 29.4% | 25.4% | |
| > 24 months | 1.8% | 0.8% | 0.43 |
| Crowding (persons/sleeping room) | |||
| Median (range) | 2.7 (0.7–9.0) | 3.0 (0.8–12.0) | |
| Birth order | |||
| 1st–2nd | 43.3% | 51.2% | |
| 3rd–4th | 27.0% | 25.2% | |
| ≥ 5th | 29.7% | 23.6% | 0.43 |
| Bathroom (%) | |||
| Field | 27.9% | 4.7% | |
| Latrine | 72.1% | 37.8% | |
| WC | 0% | 57.5% | < 0.001 |
| Drinking water, sources | |||
| Rain (%) | 85.6% | 1.6% | < 0.0001 |
| River (%) | 93.7% | 0% | < 0.0001 |
| Well (%) | 26.1% | 0% | < 0.0001 |
| Piped (%) | 36.9% | 17.1% | 0.001 |
| Potable (%) | 0% | 81.4% | < 0.0001 |
| House construction materials (%) | |||
| Wood/bamboo | 43.2 | 33.1 | |
| Wood/cement | 41.5 | 33.9 | |
| Cement/brick | 14.4 | 31.5 | |
| Other | 0.9 | 1.5 | 0.02 |
| Electrical appliances, number | |||
| 0 | 32.4 | 27.1 | |
| 1–2 | 28.8 | 22.5 | |
| 3–4 | 38.8 | 50.4 | 0.2 |
Households, especially in the rural area, have multiple sources of drinking water that vary between wet and dry seasons.
Nutritional, hematologic, and allergic characteristics by age and residence groups.
| Study group | Rural | Urban | ||||
|---|---|---|---|---|---|---|
| 6–9 months ( | 22–26 months ( | 48–60 months ( | 6–9 months ( | 22–26 months ( | 48–60 months ( | |
| Age | ||||||
| Median | 7 | 24 | 56 | 8 | 25 | 53 |
| Weight (kg) | ||||||
| Median (range) | 7.8 (6.0–9.4) | 12.0 (8.3–14.6) | 16.8 (13.3–43.1) | 7.5 (5.7–9.6) | 11.3 (8.6–14.5) | 15.5 (12.8–19.3) |
| Hematocrit (%) | ||||||
| Median (range) | 36 (30–42) | 38 (31–44) | 38 (32–43) | 36 (30–40) | 38 (32–45) | 38 (34–44) |
| White cell count (× 106 cells/mL) | ||||||
| Median (range) | 7700 (4900–15200) | 7600 (4600–14700) | 6900 (5000–18300) | 7350 (5000–13200) | 7100 (4000–14100) | 7000 (4800–12000) |
| Lymphocyte count (× 106 cells/mL) | ||||||
| Median (range) | 5126 (864–8873) | 4690 (1610–8512) | 3762 (2000–6489) | 5522 (2856–11220) | 3740 (2160–6345) | 3286 (1120–5928) |
| Neutrophil count (× 106 cells/mL) | ||||||
| Median (range) | 2156 (588–8512) | 2392 (690–6786) | 2871 (672–12078) | 1739 (584–4617) | 3108 (1120–6100) | 3483 (637–8512) |
| Eosinophil count (× 106 cells/mL) | ||||||
| Median (range) | 62 (0–304) | 156 (0–1496) | 121 (0–1700) | 63 (0–396) | 100 (0–2961) | 129 (0–714) |
| Geohelminths (%) | ||||||
| Any infection | 3.6% | 62.2% | 53.5% | 9.4% | 35.1% | 43.1% |
| | 0% | 37.8% | 20.9% | 0% | 22.9% | 22.5% |
| | 0% | 59.5% | 53.5% | 3.6% | 20.0% | 36.7% |
| | 0% | 0% | 2.3% | 0% | 0% | 0% |
| SPT (%) | ||||||
| Any allergen | 0% | 3.1% | 9.4% | 3.3% | 11.4% | 10.4% |
| House dust mite | 0% | 3.1% | 9.4% | 0% | 11.4% | 8.3% |
| Others | 0% | 0% | 6.3% | 3.3% | 0% | 2.1% |
| Wheeze, past 12 months (%) | 34.5% | 29.7% | 17.8% | 29.4% | 45.2% | 17.6% |
SPT—allergen skin prick test reactivity, Wheeze, past 12 months—episode of wheeze within past 12 months.
Missing values.
Cytokine (IL-6, IL-10, and TNF-α) and chemokine (IL-8) responses to TLR agonists. Shown are median values (interquartile range). Bold italics represent significant differences (at P < 0.01) between urban and rural infants aged 6–9 months. Numbers in bold (no italics) represent significant differences (at P < 0.01) across the 3 age groups; 6–9 (All), 22–26, and 48–60 months.
| Immune parameter for innate responses | 6–9 months (median [IQR]) | 22–26 months (median [IQR]) | 48–60 months (median [IQR]) | |||
|---|---|---|---|---|---|---|
| Urban ( | Rural ( | All ( | All ( | All ( | ||
| TLR1/2 | ||||||
| IL-6 | ng/ml | 6.5 | 8.4 | 7.2 | 4.8 | 5.3 |
| [5.8–8.6] | [7.6–9.6] | (6.1–9.6) | [3.3–9.6] | [3.5–7.3] | ||
| IL-8 | ng/ml | |||||
| [39.6–64.8] | [73.8–97.1] | [43.4–91.8] | [17.9–56.8] | [20.2–45.3] | ||
| TNF-α | pg/ml | 519 | 1,233 | 671 | 428 | 374 |
| [340–789] | [671–2500] | [340–1439] | [217–1037] | [221–914] | ||
| IL-10 | pg/ml | 399 | 431 | |||
| [312–550] | [401–480] | [317–550] | [125–406] | [171–387] | ||
| TLR3 | ||||||
| IL-6 | pg/ml | 259 | 517 | 358 | 276 | 269 |
| [77–503] | [151–955] | [77–68] | [0–681] | [34–661] | ||
| IL-8 | pg/ml | 572 | 329 | 177 | ||
| [67–572] | [1885–6503] | [112–2255] | [46–684] | [48–555] | ||
| TNF-α | pg/ml | 64 | 418 | 205 | 176 | 45 |
| [7–326] | [79–865] | [27–461] | [6–347] | [0–213] | ||
| IL-10 | pg/ml | 0 | 0 | 0 | 0 | 0 |
| [0–0] | [0–1] | [0–0] | [0–0] | [0–0] | ||
| TLR4 | ||||||
| IL-6 | ng/ml | 28.4 | 26.7 | |||
| [22.0–37.6] | [14.9–18.3] | [22.0–37.6] | [15.9–30.4] | [15.3–28.2] | ||
| IL-8 | ng/ml | |||||
| [37.0–71.2] | [60.1–98.7] | [40.7–82.3] | [21.2–65.8] | [20.9–54.1] | ||
| TNF-α | ng/ml | 7.6 | 9.9 | 8.3 | 7.0 | 6.2 |
| [3.9–10.0] | [9.7–10.0] | [5.7–10.0] | [3.9–10.0] | [4.1–9.9] | ||
| IL-10 | ng/ml | 2.0 | 1.9 | |||
| [1.6–2.0] | [1.8–2.0] | [1.6–2.0] | [1.1–2.0] | [1.1–1.9] | ||
| TLR5 | ||||||
| IL-6 | ng/ml | 18.4 | 16.2 | 17.9 | 15.2 | 13.6 |
| [16.9–23.20 | [14.9–18.3] | [15.2–23.2] | [7.7–19.6] | [8.8–18.7] | ||
| IL-8 | g/ml | |||||
| [48.9–77.5] | [87.4–98.7] | [63.7–100.0] | [32.4–75.1] | [17.0–55.4] | ||
| TNF-α | ng/ml | 3.3 | 3.2 | 3.6 | 2.3 | 2.6 |
| [2.2–5.2] | [2.0–6.2] | [2.2–6.2] | [1.2–4.8] | [1.3–4.9] | ||
| IL-10 | ng/ml | 1.5 | 1.7 | |||
| [1.1–1.9] | [0.9–2.0] | [0.9–2.0] | [0.6–1.6] | [0.6–1.4] | ||
| TLR6 | ||||||
| IL-6 | ng/ml | 1.8 | 1.9 | |||
| [1.0–2.3] | [1.3–3.0] | [1.0–2.6] | [0.4–2.3] | [0.2–1.1] | ||
| IL-8 | pg/ml | 18.7 | 31.2 | |||
| [12.0–33.0] | [27.7–55.6] | [15.6–38.9] | [3.8–21.8] | [2.5–10.7] | ||
| TNF-α | pg/ml | 57 | 121 | |||
| [3–250] | [73–682] | [28–294] | [0–5] | [0–45] | ||
| IL-10 | pg/ml | 88 | 102 | |||
| [14–222] | [74–145] | [37–174] | [0–107] | [0–57] | ||
| TLR9 | ||||||
| IL-6 | pg/ml | 0 | 0 | 0 | 0 | 0 |
| [0–12] | [0–26] | [0–0] | [0–0] | [0–0] | ||
| IL-8 | pg/ml | 777 | 763 | |||
| [334–1637] | [671–2,500] | [241–1,374] | [96–607] | [25–39] | ||
| TNF-α | pg/ml | 0 | 0 | 0 | 0 | 0 |
| [0–0] | [0–18] | [0–0] | [0–0] | [0–0] | ||
| IL-10 | pg/ml | 0 | 0 | |||
| [0–16] | [0–31] | [0–28] | [0–0] | [0–0] | ||
Functional markers of adaptive immunity shown by cytokine responses by SEB-stimulated peripheral blood leukocytes. Shown are median values (inter-quartile range). Bold italics represent significant differences (at P < 0.01) between urban and rural infants aged 6–9 months. Numbers in bold (no italics) represent significant differences (at P < 0.01) across the 3 age groups; 6–9 (All), 22–26, and 48–60 months.
| Immune parameter | 6–9 months (median [IQR]) | 22–26 months (median [IQR]) | 48–60 months (median [IQR]) | ||
|---|---|---|---|---|---|
| Urban ( | Rural ( | All ( | All ( | All ( | |
| SEB-induced cytokines (pg/ml) | |||||
| IFN-γ | 21,204 | 21,589 | 19,709 | ||
| [16,789–34,159] | [7759–23,294] | [11,309–28,369] | [14,569–38,619] | [12,239–32,829] | |
| IL-5 | 1,472 | 1,291 | |||
| [908–2350] | [767–1874] | [828–2098] | [2040–4463] | [2077–4416] | |
| IL-13 | 4677 | 5398 | 4834 | 5647 | 5530 |
| [3623–6626] | [4122–6415] | [3676–6626] | [3567–4812] | [3442–7597] | |
| IL-10 | |||||
| [811–2546] | [45–1616] | [286–2083] | [223–2141] | [41–1186] | |
Phenotypic markers of adaptive immunity. Shown are median values (inter-quartile range). Bold italics represent significant differences (at P < 0.01) between urban and rural infants aged 6–9 months. Numbers in bold (no italics) represent significant differences (at P < 0.01) across the 3 age groups; 6–9 (All), 22–26, and 48–60 months.
| Immune parameter | 6–9 months (median [IQR]) | 22–26 months (median [IQR]) | 48–60 months (median [IQR]) | ||
|---|---|---|---|---|---|
| Urban ( | Rural ( | All ( | All ( | All ( | |
| CD4+ | |||||
| Naïve (CD4+CD45RA+CD28+) | |||||
| Percentages (%) | 71.1 [60.4–73.9] | 72.8 [67.8–76.0] | |||
| Cell counts (× 106 cells/mL) | 1543 [996–1897] | 1425 [952–1964] | 1474 [991–1943] | 950 [515–1227] | 670 [403–877] |
| Memory (CD4+CD45RA−CD28+) | |||||
| Percentages (%) | 17.6 [14.5–22.0] | 18.2 [15.0–20.0] | |||
| Cell counts (× 106 cells/mL) | 355 [259–501] | 360 [252–448] | |||
| CD4+CD45RA+CD28- # | |||||
| Percentages (%) | 9.4 [6.1–13.1] | 7.1 [4.9–9.8] | 8.3 [5.2–11.3] | 8.6 [5.7–14.1] | 8.7 [5.2–12.4] |
| Cell counts (× 106 cells/mL) | 207 [102–325] | 123 [101–178] | |||
| Regulatory (CD4+CD25+FoxP3+) | |||||
| Percentages (%) | 4.1 [2.6–4.8] | 3.9 [3.3–5.4] | |||
| Cell counts (× 106 cells/mL) | 67 [43–95] | 58 [49–103] | |||
| CD8+ | |||||
| Naïve (CD8+CD45RA+CD28+) | |||||
| Percentages (%) | 37.3 [17.1–49.4] | 35.0 [25.1–52.3] | 35.9 [26.9–49.5] | 29.7 [21.5–44.4] | 31.0 [21.8–42.0] |
| Cell counts (× 106 cells/mL) | 397 [213–560] | 380 [223–526] | 389 [216–533] | 299 [193–404] | 284 [175–380] |
| Memory (CD8+CD45RA−CD28+) | |||||
| Percentages (%) | |||||
| Cell counts (× 106 cells/mL) | 49 [25–68] | 65 [42–123] | |||
| CD8+CD45RA+CD28− | |||||
| Percentages (%) | 57.4 [46.7–73.8] | 60.8 [36.8–71.8] | 59.2 [43.9–72.7] | 59.1 [42.1–74.3] | 59.8 [45.0–70.2] |
| Cell counts (× 106 cells/mL) | 577 [378–879] | 678 [238–931] | |||
This population may represent effector cells [10,11].
Figure 3Immune parameters that showed independent effects for age and residence. Shown are residence effects (rural vs. urban) by age group (6–9 months, 22–26 months, and 48–60 months). Parameters are: A. SEB-induced IL-10; B. CD8+ memory T cells; C. Percentages of Fox P3+ T regs; D. TLR3-induced IL-8; E. TLR6-induced IL-8.
Associations between environmental exposures and SEB-induced IL-10. Model 1 was adjusted for age, sex, and maternal educational level. Model 2 was adjusted for age, sex, maternal educational level and other covariates excluding residence. Shown are Fold change (FC) and 95% confidence intervals (95% CI). Environmental exposures with significant effects (P < 0.01) are shown in bold. Univar.—univariate analyses; Primary—completed primary education.
| Exposure/factor | Analysis | SEB-induced IL-10 | ||
|---|---|---|---|---|
| FC | 95% CI | |||
| Age | Univar. | |||
| Sex | Univar. | 1.83 | 0.02 | 0.09 |
| Maternal education (Illiterate vs. primary) | Univar. | 0.86 | 0.36 | 0.75 |
| Residence (urban vs. rural) | Univar. | |||
| Crowding | Model 1 | |||
| Model 2 | ||||
| Piped water | Model 1 | |||
| (yes vs. no) | Model 2 | 0.37 | 0.17 | 0.02 |
| Birth order | Model 1 | 1.08 | 0.55 | 0.83 |
| (≥ 3 rd vs. 1st/2nd) | Model 2 | 0.83 | 0.39 | 0.61 |
| Breast-feeding | Model 1 | 0.80 | 0.35 | 0.54 |
| (≥ 13 months vs. ≤ 12 months) | Model 2 | 0.70 | 0.31 | 0.39 |
| Bathroom | Model 1 | 0.41 | 0.16 | 0.07 |
| (field vs. other) | Model 2 | 0.52 | 0.19 | 0.20 |
| House construction | Model 1 | 1.05 | 0.47 | 0.91 |
| (cement vs. wood) | Model 2 | 0.21 | 0.52 | 0.65 |
| Geohelminth infection | Model 1 | 0.50 | 0.23 | 0.08 |
| (yes vs. no) | Model 2 | 0.49 | 0.24 | 0.07 |